Indian share market finished
the trading day on a positive note amid mixed international markets.
At the closing bell, the BSE Sensex
stood higher by 91 points, while the NSE Nifty
finished up by 31 points. Meanwhile, the S&P BSE Mid
Cap & the S&P BSE Small
Cap finished up by 1.2% and 1.5% respectively.
Metal
stocks and realty
sector were among the primary BSE
gainers today.
Axis
Bank share price finished the trading day on an optimistic note (up 1.9%)
after it was reported that the company is eyeing to raise up to Rs 18 billion
from debentures to fund business expansion.
In another development, Axis
Bank has reduced rates on fixed deposits of tenures between one and three
years by 25 to 50 basis points (bps).
(Looking for bank
stocks?)
At 7%, the interest rate offered by the bank on one-year deposits, is
now on par with that offered by larger rivals - ICICI Bank and HDFC Bank. (Get ICICI
Bank share price.)
Moving on to news from pharma
stocks.
According to a leading financial daily, Sun
Pharmaceutical Industries has executed definitive agreements for
acquisition of 85.1% of JSC Biosintez, a Russian pharmaceutical company engaged
in manufacture and marketing of pharmaceutical products in Russia and CIS
region.
Sun
Pharma share price finished the day up by 1.6% on the BSE.
At the time of writing the share
market news, Indian Rupee was trading at 68.52
against the US Dollar.
Read the complete stock market update. For terms of use, go here.
No comments:
Post a Comment